ArticleBMC cancer2025
Habitat-based transformer model in pretreatment
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the predictive ability of a transformer model utilizing intratumoral, peritumoral, and habitat features derived from pretreatment 18F-FDG PET imaging to assess overall survival (OS) in patients with cervical cancer.
methodsA retrospective analysis was performed using pretreatment PET data from 107 patients with cervical cancer across two medical institutions. The k-means unsupervised clustering algorithm categorized the tumor and its 4 mm peritumoral region into four distinct habitat subregions. Radiomic features were extracted from the intratumoral, peritumoral, and each habitat subregion to construct intratumoral, peritumoral, habitat, and combined transformer models. Model performance was evaluated using the area under the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis.
resultsThe habitat subregion 1 model demonstrated the highest performance. Among individual models, the habitat transformer model achieved the strongest results, with an external validation set area under the curve (AUC) of 0.778 (95% CI: 0.612–0.944), surpassing the intratumoral transformer model (AUC 0.714, 95% CI: 0.521–0.907) and the peritumoral transformer model (AUC 0.707, 95% CI: 0.517–0.896). The combined model further enhanced predictive accuracy, attaining a validation set AUC of 0.823 (95% CI: 0.677–0.970), and exhibited superior calibration and clinical applicability.
conclusionThis study highlights the efficacy of the transformer model based on 18F-FDG PET habitat features in predicting cervical cancer prognosis. The combined model, integrating intratumoral, peritumoral, and habitat features, significantly improves predictive performance and provides valuable insights for personalized treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.